跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DERMA SOLUTIONS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DERMA SOLUTIONS
Authorized
STANDARD
DERMA SOLUTIONS
larose & fils ltee
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
988c57cbd515c734
Company
larose & fils ltee
Type
Standard
Approval Details
Approval Id
988c57cbd515c734
Drug Approval Canada Name
DERMA SOLUTIONS
Product Name
DERMA SOLUTIONS
Status
Marketed
Status Date
2022-02-01
Original Market Date
2022-02-01
Din
02506300
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Topical (Household)
Schedule
OTC
Ahfs
84:04.92
Atc Original
D08AJ01 BENZALKONIUM
Atc Name
d 08 aj 01
Aig Number
0104993027
Company Name
larose & fils ltee
Company Address
2255 Boul Industriel, Laval, Quebec, Canada, H7S 1P8
Active Ingredients
BENZALKONIUM CHLORIDE
0.15 % / V/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
988c57cbd515c734
Type
Standard
Back to Health Canada Approvals